Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Neuroimaging genomics in psychiatry-a translational approach.

Mufford MS, Stein DJ, Dalvie S, Groenewold NA, Thompson PM, Jahanshad N.

Genome Med. 2017 Nov 27;9(1):102. doi: 10.1186/s13073-017-0496-z. Review.

2.

Genome-wide association study of working memory brain activation.

Blokland GAM, Wallace AK, Hansell NK, Thompson PM, Hickie IB, Montgomery GW, Martin NG, McMahon KL, de Zubicaray GI, Wright MJ.

Int J Psychophysiol. 2017 May;115:98-111. doi: 10.1016/j.ijpsycho.2016.09.010. Epub 2016 Sep 23.

PMID:
27671502
3.

Systems psychopharmacology: A network approach to developing novel therapies.

Gebicke-Haerter PJ.

World J Psychiatry. 2016 Mar 22;6(1):66-83. doi: 10.5498/wjp.v6.i1.66. eCollection 2016 Mar 22. Review.

4.

An examination of the language construct in NIMH's research domain criteria: Time for reconceptualization!

Elvevåg B, Cohen AS, Wolters MK, Whalley HC, Gountouna VE, Kuznetsova KA, Watson AR, Nicodemus KK.

Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):904-19. doi: 10.1002/ajmg.b.32438. Epub 2016 Mar 10. Review.

5.

Etiology of cardiovascular disease in patients with schizophrenia: current perspectives.

Emul M, Kalelioglu T.

Neuropsychiatr Dis Treat. 2015 Oct 1;11:2493-503. doi: 10.2147/NDT.S50006. eCollection 2015. Review.

6.

Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Hu X, Fan Q, Hou H, Yan R.

J Neurochem. 2016 Jan;136(2):234-49. doi: 10.1111/jnc.13395. Epub 2015 Nov 13. Review.

7.

mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, Galli A.

J Neurosci. 2015 Jun 10;35(23):8843-54. doi: 10.1523/JNEUROSCI.0887-15.2015.

8.

ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Douet V, Chang L, Lee K, Ernst T; Pediatric Imaging, Neurocognition, and Genetics (PING) Consortium.

Brain Imaging Behav. 2015 Mar;9(1):128-40. doi: 10.1007/s11682-015-9363-y.

9.
10.

Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions.

Gao Y, Peterson S, Masri B, Hougland MT, Adham N, Gyertyán I, Kiss B, Caron MG, El-Mallakh RS.

Pharmacol Res Perspect. 2015 Feb;3(1):e00073. doi: 10.1002/prp2.73. Epub 2014 Dec 2.

11.

Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia.

Huang CH, Pei JC, Luo DZ, Chen C, Chen YW, Lai WS.

Front Behav Neurosci. 2015 Jan 29;8:455. doi: 10.3389/fnbeh.2014.00455. eCollection 2014.

12.

Recent genetic findings in schizophrenia and their therapeutic relevance.

Harrison PJ.

J Psychopharmacol. 2015 Feb;29(2):85-96. doi: 10.1177/0269881114553647. Epub 2014 Oct 14. Review.

13.

Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Mei L, Nave KA.

Neuron. 2014 Jul 2;83(1):27-49. doi: 10.1016/j.neuron.2014.06.007. Review.

14.

Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia.

Díez A, Cieza-Borrella C, Suazo V, González-Sarmiento R, Papiol S, Molina V.

Ann Gen Psychiatry. 2014 Jun 14;13:18. doi: 10.1186/1744-859X-13-18. eCollection 2014.

15.

Identification of SNP barcode biomarkers for genes associated with facial emotion perception using particle swarm optimization algorithm.

Chuang LY, Lane HY, Lin YD, Lin MT, Yang CH, Chang HW.

Ann Gen Psychiatry. 2014 May 21;13:15. doi: 10.1186/1744-859X-13-15. eCollection 2014.

16.

Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.

Nicodemus KK, Hargreaves A, Morris D, Anney R; Schizophrenia Psychiatric Genome-wide Association Study (GWAS) Consortium; Wellcome Trust Case Control Consortium 2, Gill M, Corvin A, Donohoe G.

JAMA Psychiatry. 2014 Jul 1;71(7):778-785. doi: 10.1001/jamapsychiatry.2014.528.

17.

Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk.

Birnbaum R, Weinberger DR.

Dialogues Clin Neurosci. 2013 Sep;15(3):279-89. Review.

18.

Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJG, Gresch PJ, Airey D, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A.

Neurochem Int. 2014 Jul;73:113-121. doi: 10.1016/j.neuint.2013.09.015. Epub 2013 Sep 30.

19.

Predictive suppression of cortical excitability and its deficit in schizophrenia.

Lakatos P, Schroeder CE, Leitman DI, Javitt DC.

J Neurosci. 2013 Jul 10;33(28):11692-702. doi: 10.1523/JNEUROSCI.0010-13.2013.

20.

Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.

Penzes P, Buonanno A, Passafaro M, Sala C, Sweet RA.

J Neurochem. 2013 Jul;126(2):165-82. doi: 10.1111/jnc.12261. Epub 2013 May 22. Review.

Supplemental Content

Support Center